Literature DB >> 20436679

Critical evaluation of gamma-irradiated serum used as feeder in the culture and demonstration of putative nanobacteria and calcifying nanoparticles.

Jan Martel1, Cheng-Yeu Wu, John D Young.   

Abstract

The culture and demonstration of putative nanobacteria (NB) and calcifying nanoparticles (CNP) from human and animal tissues has relied primarily on the use of a culture supplement consisting of FBS that had been gamma-irradiated at a dose of 30 kGy (gamma-FBS). The use of gamma-FBS is based on the assumption that this sterilized fluid has been rid entirely of any residual NB/CNP, while it continues to promote the slow growth in culture of NB/CNP from human/animal tissues. We show here that gamma-irradiation (5-50 kGy) produces extensive dose-dependent serum protein breakdown as demonstrated through UV and visible light spectrophotometry, fluorometry, Fourier-transformed infrared spectroscopy, and gel electrophoresis. Yet, both gamma-FBS and gamma-irradiated human serum (gamma-HS) produce NB/CNP in cell culture conditions that are morphologically and chemically indistinguishable from their normal serum counterparts. Contrary to earlier claims, gamma-FBS does not enhance the formation of NB/CNP from several human body fluids (saliva, urine, ascites, and synovial fluid) tested. In the presence of additional precipitating ions, both gamma-irradiated serum (FBS and HS) and gamma-irradiated proteins (albumin and fetuin-A) retain the inherent dual NB inhibitory and seeding capabilities seen also with their untreated counterparts. By gel electrophoresis, the particles formed from both gamma-FBS and gamma-HS are seen to have assimilated into their scaffold the same smeared protein profiles found in the gamma-irradiated sera. However, their protein compositions as identified by proteomics are virtually identical to those seen with particles formed from untreated serum. Moreover, particles derived from human fluids and cultured in the presence of gamma-FBS contain proteins derived from both gamma-FBS and the human fluid under investigation-a confusing and unprecedented scenario indicating that these particles harbor proteins from both the host tissue and the FBS used as feeder. Thus, the NB/CNP described in the literature clearly bear hybrid protein compositions belonging to different species. We conclude that there is no basis to justify the use of gamma-FBS as a feeder for the growth and demonstration of NB/CNP or any NB-like particles in culture. Moreover, our results call into question the validity of the entire body of literature accumulated to date on NB and CNP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20436679      PMCID: PMC2859944          DOI: 10.1371/journal.pone.0010343

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  100 in total

1.  Detection of nanobacteria in serum, bile and gallbladder mucosa of patients with cholecystolithiasis.

Authors:  Yu Wen; Yong-guo Li; Zhu-lin Yang; Xue-jun Wang; Hong Wei; Wei Liu; Xiong-ying Miao; Qun-wei Wang; Sheng-fu Huang; Jing Yang; E Olavi Kajander; Neva Ciftcioglu
Journal:  Chin Med J (Engl)       Date:  2005-03-05       Impact factor: 2.628

Review 2.  Do calcifying nanoparticles promote nephrolithiasis? A review of the evidence.

Authors:  F A Shiekh; V M Miller; J C Lieske
Journal:  Clin Nephrol       Date:  2009-01       Impact factor: 0.975

3.  Albumin/calcium association at different pH, as determined by potentiometry.

Authors:  N Fogh-Andersen
Journal:  Clin Chem       Date:  1977-11       Impact factor: 8.327

Review 4.  Cell biology of pathologic renal calcification: contribution of crystal transcytosis, cell-mediated calcification, and nanoparticles.

Authors:  Vivek Kumar; Gerard Farell; Shihui Yu; Sean Harrington; Lorraine Fitzpatrick; Ewa Rzewuska; Virginia M Miller; John C Lieske
Journal:  J Investig Med       Date:  2006-11       Impact factor: 2.895

5.  Heme activates artemisinin more efficiently than hemin, inorganic iron, or hemoglobin.

Authors:  Shiming Zhang; Glenn S Gerhard
Journal:  Bioorg Med Chem       Date:  2008-02-14       Impact factor: 3.641

6.  Systemic injection of planktonic forms of mammalian-derived nanoparticles alters arterial response to injury in rabbits.

Authors:  Maria K Schwartz; John C Lieske; Larry W Hunter; Virginia M Miller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

7.  Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads.

Authors:  Terence M Doherty; Kamlesh Asotra; Lorraine A Fitzpatrick; Jian-Hua Qiao; Douglas J Wilkin; Robert C Detrano; Colin R Dunstan; Prediman K Shah; Tripathi B Rajavashisth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-19       Impact factor: 11.205

8.  Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles.

Authors:  Alexander Heiss; Thomas Eckert; Anke Aretz; Walter Richtering; Wim van Dorp; Cora Schäfer; Willi Jahnen-Dechent
Journal:  J Biol Chem       Date:  2008-03-25       Impact factor: 5.157

9.  Association between Randall's plaque and calcifying nanoparticles.

Authors:  Neva Ciftçioğlu; Kaveh Vejdani; Olivia Lee; Grace Mathew; Katja M Aho; E Olavi Kajander; David S McKay; Jeffrey A Jones; Marshall L Stoller
Journal:  Int J Nanomedicine       Date:  2008

10.  Nanobacteria are mineralo fetuin complexes.

Authors:  Didier Raoult; Michel Drancourt; Saïd Azza; Claude Nappez; Régis Guieu; Jean-Marc Rolain; Patrick Fourquet; Bernard Campagna; Bernard La Scola; Jean-Louis Mege; Pascal Mansuelle; Eric Lechevalier; Yvon Berland; Jean-Pierre Gorvel; Patricia Renesto
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

View more
  14 in total

1.  Membrane vesicles nucleate mineralo-organic nanoparticles and induce carbonate apatite precipitation in human body fluids.

Authors:  Cheng-Yeu Wu; Jan Martel; Wei-Yun Cheng; Chao-Chih He; David M Ojcius; John D Young
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

Review 2.  [Current concepts on the pathogenesis of urinary stones].

Authors:  R Mager; A Neisius
Journal:  Urologe A       Date:  2019-11       Impact factor: 0.639

3.  Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel.

Authors:  Sara A Abouelmagd; Youn Jin Ku; Yoon Yeo
Journal:  J Drug Target       Date:  2015       Impact factor: 5.121

4.  Calcium-based nanoparticles accelerate skin wound healing.

Authors:  Kenichiro Kawai; Barrett J Larson; Hisako Ishise; Antoine Lyonel Carre; Soh Nishimoto; Michael Longaker; H Peter Lorenz
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

Review 5.  The role of calcifying nanoparticles in biology and medicine.

Authors:  Anton G Kutikhin; Elena B Brusina; Arseniy E Yuzhalin
Journal:  Int J Nanomedicine       Date:  2012-01-19

Review 6.  Nanobacteria in the pathogenesis of urolithiasis: Myth or reality?

Authors:  Nitin Abrol; Arabind Panda; Nitin S Kekre; Antony Devasia
Journal:  Indian J Urol       Date:  2015 Jan-Mar

7.  Cytotoxicity and apoptosis induced by nanobacteria in human breast cancer cells.

Authors:  Ming-jun Zhang; Sheng-nan Liu; Ge Xu; Ya-nan Guo; Jian-nan Fu; De-chun Zhang
Journal:  Int J Nanomedicine       Date:  2013-12-30

8.  Bions: a family of biomimetic mineralo-organic complexes derived from biological fluids.

Authors:  Cheng-Yeu Wu; Lena Young; David Young; Jan Martel; John D Young
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

Review 9.  Clinical implications of calcifying nanoparticles in dental diseases: a critical review.

Authors:  Mohammed S Alenazy; Hezekiah A Mosadomi
Journal:  Int J Nanomedicine       Date:  2013-12-11

10.  Detection and characterization of mineralo-organic nanoparticles in human kidneys.

Authors:  Tsui-Yin Wong; Cheng-Yeu Wu; Jan Martel; Cheng-Wei Lin; Fu-Yung Hsu; David M Ojcius; Paul Y Lin; John D Young
Journal:  Sci Rep       Date:  2015-10-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.